Skip to content
Recall Observatory FDA recall evidence

Device product

Tosoh ST AIA-PACK HbA1c Control, HbA1c Control, PN 025418 The product is intended for In Vitro Diagnostic Use Only for performing quality control procedures with the HbA1c Assay.

Z-1811-2018

March 05, 2018

Class II

Product summary

Firm
Tosoh Bioscience Inc
Event
Event 79708
Status
Terminated
Classification
Class II
Quantity
2864
Official record key
device-enforcement:Z-1811-2018

Official wording

Reason: The assay can potentially generate erroneously elevated or erroneously decreased HbA1c patient results.

Code information: All lots.

Distribution pattern: USA (nationwide) Distribution including PR and to the states of : AL, AR, AZ, CA, CO, CT, FL, GA, IA, ID, IL, KS, KY, LA, MA, MD, MI, MO, NC, NE, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV, and WY.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    The assay can potentially generate erroneously elevated or erroneously decreased HbA1c patient results.